Global Recombinant Proteins Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 260982
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Recombinant Proteins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Recombinant Proteins market size is estimated to be worth US$ 740.2 million in 2021 and is forecast to a readjusted size of USD 1248.3 million by 2028 with a CAGR of 7.8% during review period. Biopharmaceutical Companies accounting for % of the Recombinant Proteins global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hormones segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Recombinant Proteins include Abcam PLC, R&D Systems, Miltenyi Biotec, Thermo Fisher Scientific, and Sigma Aldrich Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Recombinant Proteins market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hormones

Growth Factors

Cytokines

Plasma Protein Factor

Recombinant Metabolic Enzymes

Immune Checkpoint Regulators

Others

Market segment by Application, can be divided into

Biopharmaceutical Companies

Academic and Research Institutes

Contract Research Organizations

Market segment by players, this report covers

Abcam PLC

R&D Systems

Miltenyi Biotec

Thermo Fisher Scientific

Sigma Aldrich Company

GE Healthcare

Lonza

Merck KGaA

ProSpec Tany TechnoGene

Eurogentec (Kaneka Corporation)

PeproTech

BPS Bioscience

Reprocell

GenScript Biotech Corporation

Abnova Corporation

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Recombinant Proteins product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Recombinant Proteins, with revenue, gross margin and global market share of Recombinant Proteins from 2019 to 2022.

Chapter 3, the Recombinant Proteins competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Recombinant Proteins market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Recombinant Proteins research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Recombinant Proteins

1.2 Classification of Recombinant Proteins by Type

1.2.1 Overview: Global Recombinant Proteins Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Recombinant Proteins Revenue Market Share by Type in 2021

1.2.3 Hormones

1.2.4 Growth Factors

1.2.5 Cytokines

1.2.6 Plasma Protein Factor

1.2.7 Recombinant Metabolic Enzymes

1.2.8 Immune Checkpoint Regulators

1.2.9 Others

1.3 Global Recombinant Proteins Market by Application

1.3.1 Overview: Global Recombinant Proteins Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Biopharmaceutical Companies

1.3.3 Academic and Research Institutes

1.3.4 Contract Research Organizations

1.4 Global Recombinant Proteins Market Size & Forecast

1.5 Global Recombinant Proteins Market Size and Forecast by Region

1.5.1 Global Recombinant Proteins Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Recombinant Proteins Market Size by Region, (2017-2022)

1.5.3 North America Recombinant Proteins Market Size and Prospect (2017-2028)

1.5.4 Europe Recombinant Proteins Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Recombinant Proteins Market Size and Prospect (2017-2028)

1.5.6 South America Recombinant Proteins Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Recombinant Proteins Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Recombinant Proteins Market Drivers

1.6.2 Recombinant Proteins Market Restraints

1.6.3 Recombinant Proteins Trends Analysis

2 Company Profiles

2.1 Abcam PLC

2.1.1 Abcam PLC Details

2.1.2 Abcam PLC Major Business

2.1.3 Abcam PLC Recombinant Proteins Product and Solutions

2.1.4 Abcam PLC Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Abcam PLC Recent Developments and Future Plans

2.2 R&D Systems

2.2.1 R&D Systems Details

2.2.2 R&D Systems Major Business

2.2.3 R&D Systems Recombinant Proteins Product and Solutions

2.2.4 R&D Systems Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 R&D Systems Recent Developments and Future Plans

2.3 Miltenyi Biotec

2.3.1 Miltenyi Biotec Details

2.3.2 Miltenyi Biotec Major Business

2.3.3 Miltenyi Biotec Recombinant Proteins Product and Solutions

2.3.4 Miltenyi Biotec Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Miltenyi Biotec Recent Developments and Future Plans

2.4 Thermo Fisher Scientific

2.4.1 Thermo Fisher Scientific Details

2.4.2 Thermo Fisher Scientific Major Business

2.4.3 Thermo Fisher Scientific Recombinant Proteins Product and Solutions

2.4.4 Thermo Fisher Scientific Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.5 Sigma Aldrich Company

2.5.1 Sigma Aldrich Company Details

2.5.2 Sigma Aldrich Company Major Business

2.5.3 Sigma Aldrich Company Recombinant Proteins Product and Solutions

2.5.4 Sigma Aldrich Company Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Sigma Aldrich Company Recent Developments and Future Plans

2.6 GE Healthcare

2.6.1 GE Healthcare Details

2.6.2 GE Healthcare Major Business

2.6.3 GE Healthcare Recombinant Proteins Product and Solutions

2.6.4 GE Healthcare Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 GE Healthcare Recent Developments and Future Plans

2.7 Lonza

2.7.1 Lonza Details

2.7.2 Lonza Major Business

2.7.3 Lonza Recombinant Proteins Product and Solutions

2.7.4 Lonza Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Lonza Recent Developments and Future Plans

2.8 Merck KGaA

2.8.1 Merck KGaA Details

2.8.2 Merck KGaA Major Business

2.8.3 Merck KGaA Recombinant Proteins Product and Solutions

2.8.4 Merck KGaA Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Merck KGaA Recent Developments and Future Plans

2.9 ProSpec Tany TechnoGene

2.9.1 ProSpec Tany TechnoGene Details

2.9.2 ProSpec Tany TechnoGene Major Business

2.9.3 ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions

2.9.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 ProSpec Tany TechnoGene Recent Developments and Future Plans

2.10 Eurogentec (Kaneka Corporation)

2.10.1 Eurogentec (Kaneka Corporation) Details

2.10.2 Eurogentec (Kaneka Corporation) Major Business

2.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions

2.10.4 Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Eurogentec (Kaneka Corporation) Recent Developments and Future Plans

2.11 PeproTech

2.11.1 PeproTech Details

2.11.2 PeproTech Major Business

2.11.3 PeproTech Recombinant Proteins Product and Solutions

2.11.4 PeproTech Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 PeproTech Recent Developments and Future Plans

2.12 BPS Bioscience

2.12.1 BPS Bioscience Details

2.12.2 BPS Bioscience Major Business

2.12.3 BPS Bioscience Recombinant Proteins Product and Solutions

2.12.4 BPS Bioscience Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 BPS Bioscience Recent Developments and Future Plans

2.13 Reprocell

2.13.1 Reprocell Details

2.13.2 Reprocell Major Business

2.13.3 Reprocell Recombinant Proteins Product and Solutions

2.13.4 Reprocell Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Reprocell Recent Developments and Future Plans

2.14 GenScript Biotech Corporation

2.14.1 GenScript Biotech Corporation Details

2.14.2 GenScript Biotech Corporation Major Business

2.14.3 GenScript Biotech Corporation Recombinant Proteins Product and Solutions

2.14.4 GenScript Biotech Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 GenScript Biotech Corporation Recent Developments and Future Plans

2.15 Abnova Corporation

2.15.1 Abnova Corporation Details

2.15.2 Abnova Corporation Major Business

2.15.3 Abnova Corporation Recombinant Proteins Product and Solutions

2.15.4 Abnova Corporation Recombinant Proteins Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Abnova Corporation Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Recombinant Proteins Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Recombinant Proteins Players Market Share in 2021

3.2.2 Top 10 Recombinant Proteins Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Recombinant Proteins Players Head Office, Products and Services Provided

3.4 Recombinant Proteins Mergers & Acquisitions

3.5 Recombinant Proteins New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Recombinant Proteins Revenue and Market Share by Type (2017-2022)

4.2 Global Recombinant Proteins Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Recombinant Proteins Revenue Market Share by Application (2017-2022)

5.2 Global Recombinant Proteins Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Recombinant Proteins Revenue by Type (2017-2028)

6.2 North America Recombinant Proteins Revenue by Application (2017-2028)

6.3 North America Recombinant Proteins Market Size by Country

6.3.1 North America Recombinant Proteins Revenue by Country (2017-2028)

6.3.2 United States Recombinant Proteins Market Size and Forecast (2017-2028)

6.3.3 Canada Recombinant Proteins Market Size and Forecast (2017-2028)

6.3.4 Mexico Recombinant Proteins Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Recombinant Proteins Revenue by Type (2017-2028)

7.2 Europe Recombinant Proteins Revenue by Application (2017-2028)

7.3 Europe Recombinant Proteins Market Size by Country

7.3.1 Europe Recombinant Proteins Revenue by Country (2017-2028)

7.3.2 Germany Recombinant Proteins Market Size and Forecast (2017-2028)

7.3.3 France Recombinant Proteins Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Recombinant Proteins Market Size and Forecast (2017-2028)

7.3.5 Russia Recombinant Proteins Market Size and Forecast (2017-2028)

7.3.6 Italy Recombinant Proteins Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Recombinant Proteins Revenue by Type (2017-2028)

8.2 Asia-Pacific Recombinant Proteins Revenue by Application (2017-2028)

8.3 Asia-Pacific Recombinant Proteins Market Size by Region

8.3.1 Asia-Pacific Recombinant Proteins Revenue by Region (2017-2028)

8.3.2 China Recombinant Proteins Market Size and Forecast (2017-2028)

8.3.3 Japan Recombinant Proteins Market Size and Forecast (2017-2028)

8.3.4 South Korea Recombinant Proteins Market Size and Forecast (2017-2028)

8.3.5 India Recombinant Proteins Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Recombinant Proteins Market Size and Forecast (2017-2028)

8.3.7 Australia Recombinant Proteins Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Recombinant Proteins Revenue by Type (2017-2028)

9.2 South America Recombinant Proteins Revenue by Application (2017-2028)

9.3 South America Recombinant Proteins Market Size by Country

9.3.1 South America Recombinant Proteins Revenue by Country (2017-2028)

9.3.2 Brazil Recombinant Proteins Market Size and Forecast (2017-2028)

9.3.3 Argentina Recombinant Proteins Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Recombinant Proteins Revenue by Type (2017-2028)

10.2 Middle East & Africa Recombinant Proteins Revenue by Application (2017-2028)

10.3 Middle East & Africa Recombinant Proteins Market Size by Country

10.3.1 Middle East & Africa Recombinant Proteins Revenue by Country (2017-2028)

10.3.2 Turkey Recombinant Proteins Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Recombinant Proteins Market Size and Forecast (2017-2028)

10.3.4 UAE Recombinant Proteins Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Recombinant Proteins Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Recombinant Proteins Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Recombinant Proteins Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Recombinant Proteins Revenue (USD Million) by Region (2017-2022)

Table 5. Global Recombinant Proteins Revenue Market Share by Region (2023-2028)

Table 6. Abcam PLC Corporate Information, Head Office, and Major Competitors

Table 7. Abcam PLC Major Business

Table 8. Abcam PLC Recombinant Proteins Product and Solutions

Table 9. Abcam PLC Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. R&D Systems Corporate Information, Head Office, and Major Competitors

Table 11. R&D Systems Major Business

Table 12. R&D Systems Recombinant Proteins Product and Solutions

Table 13. R&D Systems Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Miltenyi Biotec Corporate Information, Head Office, and Major Competitors

Table 15. Miltenyi Biotec Major Business

Table 16. Miltenyi Biotec Recombinant Proteins Product and Solutions

Table 17. Miltenyi Biotec Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 19. Thermo Fisher Scientific Major Business

Table 20. Thermo Fisher Scientific Recombinant Proteins Product and Solutions

Table 21. Thermo Fisher Scientific Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Sigma Aldrich Company Corporate Information, Head Office, and Major Competitors

Table 23. Sigma Aldrich Company Major Business

Table 24. Sigma Aldrich Company Recombinant Proteins Product and Solutions

Table 25. Sigma Aldrich Company Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 27. GE Healthcare Major Business

Table 28. GE Healthcare Recombinant Proteins Product and Solutions

Table 29. GE Healthcare Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Lonza Corporate Information, Head Office, and Major Competitors

Table 31. Lonza Major Business

Table 32. Lonza Recombinant Proteins Product and Solutions

Table 33. Lonza Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Merck KGaA Corporate Information, Head Office, and Major Competitors

Table 35. Merck KGaA Major Business

Table 36. Merck KGaA Recombinant Proteins Product and Solutions

Table 37. Merck KGaA Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. ProSpec Tany TechnoGene Corporate Information, Head Office, and Major Competitors

Table 39. ProSpec Tany TechnoGene Major Business

Table 40. ProSpec Tany TechnoGene Recombinant Proteins Product and Solutions

Table 41. ProSpec Tany TechnoGene Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Eurogentec (Kaneka Corporation) Corporate Information, Head Office, and Major Competitors

Table 43. Eurogentec (Kaneka Corporation) Major Business

Table 44. Eurogentec (Kaneka Corporation) Recombinant Proteins Product and Solutions

Table 45. Eurogentec (Kaneka Corporation) Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. PeproTech Corporate Information, Head Office, and Major Competitors

Table 47. PeproTech Major Business

Table 48. PeproTech Recombinant Proteins Product and Solutions

Table 49. PeproTech Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. BPS Bioscience Corporate Information, Head Office, and Major Competitors

Table 51. BPS Bioscience Major Business

Table 52. BPS Bioscience Recombinant Proteins Product and Solutions

Table 53. BPS Bioscience Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Reprocell Corporate Information, Head Office, and Major Competitors

Table 55. Reprocell Major Business

Table 56. Reprocell Recombinant Proteins Product and Solutions

Table 57. Reprocell Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. GenScript Biotech Corporation Corporate Information, Head Office, and Major Competitors

Table 59. GenScript Biotech Corporation Major Business

Table 60. GenScript Biotech Corporation Recombinant Proteins Product and Solutions

Table 61. GenScript Biotech Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Abnova Corporation Corporate Information, Head Office, and Major Competitors

Table 63. Abnova Corporation Major Business

Table 64. Abnova Corporation Recombinant Proteins Product and Solutions

Table 65. Abnova Corporation Recombinant Proteins Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global Recombinant Proteins Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global Recombinant Proteins Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of Recombinant Proteins by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Recombinant Proteins Players Head Office, Products and Services Provided

Table 70. Recombinant Proteins Mergers & Acquisitions in the Past Five Years

Table 71. Recombinant Proteins New Entrants and Expansion Plans

Table 72. Global Recombinant Proteins Revenue (USD Million) by Type (2017-2022)

Table 73. Global Recombinant Proteins Revenue Share by Type (2017-2022)

Table 74. Global Recombinant Proteins Revenue Forecast by Type (2023-2028)

Table 75. Global Recombinant Proteins Revenue by Application (2017-2022)

Table 76. Global Recombinant Proteins Revenue Forecast by Application (2023-2028)

Table 77. North America Recombinant Proteins Revenue by Type (2017-2022) & (USD Million)

Table 78. North America Recombinant Proteins Revenue by Type (2023-2028) & (USD Million)

Table 79. North America Recombinant Proteins Revenue by Application (2017-2022) & (USD Million)

Table 80. North America Recombinant Proteins Revenue by Application (2023-2028) & (USD Million)

Table 81. North America Recombinant Proteins Revenue by Country (2017-2022) & (USD Million)

Table 82. North America Recombinant Proteins Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe Recombinant Proteins Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe Recombinant Proteins Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe Recombinant Proteins Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe Recombinant Proteins Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe Recombinant Proteins Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe Recombinant Proteins Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific Recombinant Proteins Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific Recombinant Proteins Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific Recombinant Proteins Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific Recombinant Proteins Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific Recombinant Proteins Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific Recombinant Proteins Revenue by Region (2023-2028) & (USD Million)

Table 95. South America Recombinant Proteins Revenue by Type (2017-2022) & (USD Million)

Table 96. South America Recombinant Proteins Revenue by Type (2023-2028) & (USD Million)

Table 97. South America Recombinant Proteins Revenue by Application (2017-2022) & (USD Million)

Table 98. South America Recombinant Proteins Revenue by Application (2023-2028) & (USD Million)

Table 99. South America Recombinant Proteins Revenue by Country (2017-2022) & (USD Million)

Table 100. South America Recombinant Proteins Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa Recombinant Proteins Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa Recombinant Proteins Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa Recombinant Proteins Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa Recombinant Proteins Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa Recombinant Proteins Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa Recombinant Proteins Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Recombinant Proteins Picture

Figure 2. Global Recombinant Proteins Revenue Market Share by Type in 2021

Figure 3. Hormones

Figure 4. Growth Factors

Figure 5. Cytokines

Figure 6. Plasma Protein Factor

Figure 7. Recombinant Metabolic Enzymes

Figure 8. Immune Checkpoint Regulators

Figure 9. Others

Figure 10. Recombinant Proteins Revenue Market Share by Application in 2021

Figure 11. Biopharmaceutical Companies Picture

Figure 12. Academic and Research Institutes Picture

Figure 13. Contract Research Organizations Picture

Figure 14. Global Recombinant Proteins Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 15. Global Recombinant Proteins Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global Recombinant Proteins Revenue Market Share by Region (2017-2028)

Figure 17. Global Recombinant Proteins Revenue Market Share by Region in 2021

Figure 18. North America Recombinant Proteins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Europe Recombinant Proteins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Asia-Pacific Recombinant Proteins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. South America Recombinant Proteins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Middle East and Africa Recombinant Proteins Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Recombinant Proteins Market Drivers

Figure 24. Recombinant Proteins Market Restraints

Figure 25. Recombinant Proteins Market Trends

Figure 26. Abcam PLC Recent Developments and Future Plans

Figure 27. R&D Systems Recent Developments and Future Plans

Figure 28. Miltenyi Biotec Recent Developments and Future Plans

Figure 29. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 30. Sigma Aldrich Company Recent Developments and Future Plans

Figure 31. GE Healthcare Recent Developments and Future Plans

Figure 32. Lonza Recent Developments and Future Plans

Figure 33. Merck KGaA Recent Developments and Future Plans

Figure 34. ProSpec Tany TechnoGene Recent Developments and Future Plans

Figure 35. Eurogentec (Kaneka Corporation) Recent Developments and Future Plans

Figure 36. PeproTech Recent Developments and Future Plans

Figure 37. BPS Bioscience Recent Developments and Future Plans

Figure 38. Reprocell Recent Developments and Future Plans

Figure 39. GenScript Biotech Corporation Recent Developments and Future Plans

Figure 40. Abnova Corporation Recent Developments and Future Plans

Figure 41. Global Recombinant Proteins Revenue Share by Players in 2021

Figure 42. Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 43. Global Top 3 Players Recombinant Proteins Revenue Market Share in 2021

Figure 44. Global Top 10 Players Recombinant Proteins Revenue Market Share in 2021

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 46. Global Recombinant Proteins Revenue Share by Type in 2021

Figure 47. Global Recombinant Proteins Market Share Forecast by Type (2023-2028)

Figure 48. Global Recombinant Proteins Revenue Share by Application in 2021

Figure 49. Global Recombinant Proteins Market Share Forecast by Application (2023-2028)

Figure 50. North America Recombinant Proteins Sales Market Share by Type (2017-2028)

Figure 51. North America Recombinant Proteins Sales Market Share by Application (2017-2028)

Figure 52. North America Recombinant Proteins Revenue Market Share by Country (2017-2028)

Figure 53. United States Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Canada Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Mexico Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Europe Recombinant Proteins Sales Market Share by Type (2017-2028)

Figure 57. Europe Recombinant Proteins Sales Market Share by Application (2017-2028)

Figure 58. Europe Recombinant Proteins Revenue Market Share by Country (2017-2028)

Figure 59. Germany Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. France Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. United Kingdom Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Russia Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Italy Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Asia-Pacific Recombinant Proteins Sales Market Share by Type (2017-2028)

Figure 65. Asia-Pacific Recombinant Proteins Sales Market Share by Application (2017-2028)

Figure 66. Asia-Pacific Recombinant Proteins Revenue Market Share by Region (2017-2028)

Figure 67. China Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Japan Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. South Korea Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. India Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Southeast Asia Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Australia Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. South America Recombinant Proteins Sales Market Share by Type (2017-2028)

Figure 74. South America Recombinant Proteins Sales Market Share by Application (2017-2028)

Figure 75. South America Recombinant Proteins Revenue Market Share by Country (2017-2028)

Figure 76. Brazil Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Argentina Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Middle East and Africa Recombinant Proteins Sales Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Recombinant Proteins Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Recombinant Proteins Revenue Market Share by Country (2017-2028)

Figure 81. Turkey Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Saudi Arabia Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. UAE Recombinant Proteins Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz